ARI is not backed by Bosley. Both ARI and Bosley are owned by Aderans Holding Co Ltd. They are a huge Japanese company whose main business is making wigs and they are one of the biggest companies in the world doing so right now.Alejandro said:Take Ari, I dont think they will be sold to a big company. They got a big player with bosley behind them, Histogen might be sold but i dont think Ari will
So ask yourself this. Why would a wig manufacture choose to pursue hair multiplication. Gee I can only think of one reason. The Future!
I have no inside knowledge about them but common sense will tell you that they see possibilities in a therapy that would advance their existing interests. I would also think that purchasing Bosley gives them a foot in the door when it comes to a way to sell and administer the procedure if and when it becomes available.
As for large drug companies wanting to buy something like Histogen all you have to do is look up Dr. Marty Sawaya's opinions (a very respected researcher of hair loss) and as she says most drug companies are focused on disease-oriented conditions.
Drugs that are life saving. Let's face it no insurance company is going to cover a procedure like Histogen. I think that if they show continued success there will be a line of outside investors willing to invest.
There is no telling if any of these companies are truly on track. The one thing we do know is that at no other time in the last 20 years have companies been researching hair loss the way they are now.
Fingers Crossed.